← Open Payments lookup

DANIELLE FOWLER: Open Payments

NPI 1053007831 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$847 in 28 payments from 9 companies in 2025. Trend: 2023 $60 · 2024 $776 · 2025 $847

Food & beverage: $847
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$288
Novo Nordisk Inc5$135
Amgen Inc.1$126
Novartis Pharmaceuticals Corporation6$108
E.R. Squibb & Sons, L.L.C.1$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)4$53
ABIOMED2$37
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Merck Sharp & Dohme LLC1$19

Products named: REPATHA, Wegovy, LEQVIO, FARXIGA, ELIQUIS, LifeVest, Ozempic, JARDIANCE.

Industry payments across ID — which companies pay providers there.